deafness | GenomeWeb


BEIJING — Like many microarray vendors, CapitalBio sees future growth opportunities in molecular diagnostics.

By Molika Ashford
In the hunt for the genetic causes of hearing loss in local populations, researchers at Tel Aviv University have taken up targeted genomic capture and deep sequencing to root out causative mutations.

At an FDA workshop last month, Lynn Bry spoke in a panel session about the need for a clinically annotated database of variants, detailing how Partners HealthCare Center for Personalized Medicine had developed such a database that is using for its sequencing-based diagnostic tests.

"Next-gen sequencing is going to turn diagnostics completely upside down and on its head," Richard Resnick, CEO of GenomeQuest, said at a recent panel discussion on next-gen sequencing-based diagnostics.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.